The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-amino-4-hydroxy-3-((4-(4-((2-hydroxy-8-sulfonaphthalen-1-yl)diazenyl)phenylsulfonyl)phenyl)diazenyl)naphthalene-2,7-disulfonic acid ID: ALA1269670
Chembl Id: CHEMBL1269670
PubChem CID: 136002676
Max Phase: Preclinical
Molecular Formula: C32H23N5O13S4
Molecular Weight: 813.83
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms: NSC-12129
Canonical SMILES: Nc1cc(S(=O)(=O)O)cc2cc(S(=O)(=O)O)c(/N=N/c3ccc(S(=O)(=O)c4ccc(/N=N/c5c(O)ccc6cccc(S(=O)(=O)O)c56)cc4)cc3)c(O)c12
Standard InChI: InChI=1S/C32H23N5O13S4/c33-24-16-23(52(42,43)44)14-18-15-27(54(48,49)50)31(32(39)28(18)24)37-35-20-7-11-22(12-8-20)51(40,41)21-9-5-19(6-10-21)34-36-30-25(38)13-4-17-2-1-3-26(29(17)30)53(45,46)47/h1-16,38-39H,33H2,(H,42,43,44)(H,45,46,47)(H,48,49,50)/b36-34+,37-35+
Standard InChI Key: BHUDDCVUAVZQAL-VHJMTFITSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 813.83Molecular Weight (Monoisotopic): 813.0175AlogP: 6.39#Rotatable Bonds: 9Polar Surface Area: 313.17Molecular Species: ACIDHBA: 15HBD: 6#RO5 Violations: 4HBA (Lipinski): 18HBD (Lipinski): 7#RO5 Violations (Lipinski): 4CX Acidic pKa: -3.95CX Basic pKa: 1.97CX LogP: 1.32CX LogD: -1.30Aromatic Rings: 6Heavy Atoms: 54QED Weighted: 0.05Np Likeness Score: -0.34
References 1. Sierecki E, Sinko W, McCammon JA, Newton AC.. (2010) Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening., 53 (19): [PMID:20836557 ] [10.1021/jm100331d ]